Table of Contents
Chapter 1. Global Diabetic Kidney Disease Market Executive Summary
1.1. Global Diabetic Kidney Disease Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Route of Administration
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Diabetic Kidney Disease Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Diabetic Kidney Disease Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Diabetes
3.1.2. Increasing Geriatric Population
3.1.3. Technological Advancements in Diagnostics and Treatment
3.2. Market Challenges
3.2.1. High Treatment Costs
3.2.2. Lack of Awareness in Low-Income Regions
3.3. Market Opportunities
3.3.1. Growth in Healthcare Investments in Emerging Markets
3.3.2. Increasing Focus on Early Screening Programs
3.3.3. Development of New Molecular Entities
Chapter 4. Global Diabetic Kidney Disease Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Diabetic Kidney Disease Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Diabetic Kidney Disease Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Angiotensin Receptor Blockers (ARBs)
5.2.2. Calcium Channel Blockers
5.2.3. Antioxidant Inflammation Modulator
5.2.4. Angiotensin-Converting Enzyme (ACE) Inhibitors
5.2.5. Others
Chapter 6. Global Diabetic Kidney Disease Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Diabetic Kidney Disease Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oral
6.2.2. Parenteral
Chapter 7. Global Diabetic Kidney Disease Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Diabetic Kidney Disease Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Global Diabetic Kidney Disease Market Size & Forecasts by Region 2022-2032
8.1. North America Diabetic Kidney Disease Market
8.1.1. U.S. Diabetic Kidney Disease Market
8.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Diabetic Kidney Disease Market
8.1.2.1. Drug Class breakdown size & forecasts, 2022-2032
8.1.2.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.2.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.2. Europe Diabetic Kidney Disease Market
8.2.1. U.K. Diabetic Kidney Disease Market
8.2.2. Germany Diabetic Kidney Disease Market
8.2.3. France Diabetic Kidney Disease Market
8.2.4. Spain Diabetic Kidney Disease Market
8.2.5. Italy Diabetic Kidney Disease Market
8.2.6. Rest of Europe Diabetic Kidney Disease Market
8.3. Asia-Pacific Diabetic Kidney Disease Market
8.3.1. China Diabetic Kidney Disease Market
8.3.2. India Diabetic Kidney Disease Market
8.3.3. Japan Diabetic Kidney Disease Market
8.3.4. Australia Diabetic Kidney Disease Market
8.3.5. South Korea Diabetic Kidney Disease Market
8.3.6. Rest of Asia Pacific Diabetic Kidney Disease Market
8.4. Latin America Diabetic Kidney Disease Market
8.4.1. Brazil Diabetic Kidney Disease Market
8.4.2. Mexico Diabetic Kidney Disease Market
8.4.3. Rest of Latin America Diabetic Kidney Disease Market
8.5. Middle East & Africa Diabetic Kidney Disease Market
8.5.1. Saudi Arabia Diabetic Kidney Disease Market
8.5.2. South Africa Diabetic Kidney Disease Market
8.5.3. Rest of Middle East & Africa Diabetic Kidney Disease Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AstraZeneca
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Boehringer Ingelheim
9.3.3. Janssen Pharmaceuticals
9.3.4. Bristol Myers Squibb
9.3.5. GSK
9.3.6. Novo Nordisk
9.3.7. Eli Lilly and Company
9.3.8. Merck & Co.
9.3.9. Sanofi
9.3.10. AbbVie
9.3.11. Sun Pharmaceutical Industries Ltd
9.3.12. Teva Pharmaceutical Industries Ltd
9.3.13. Lupin
9.3.14. Aurobindo Pharma
9.3.15. Takeda Pharmaceutical Company Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes